Projects per year
Fingerprint
Dive into the research topics where Sharad A Ghamande is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
-
MCG Minority-Based Community Clinical Oncology Program
Jillella, A., Ghamande, S. A., JILLELLA, A. P., JILLELLA, A. P., GHAMANDE, S., KALLAB, A., JILLELLA, A. P. & KALLAB, A. M.
Project: Research project
Research output
-
Immune activation in patients with locally advanced cervical cancer treated with ipilimumab following definitive chemoradiation (GOG-9929)
da Silva, D. M., Enserro, D. M., Mayadev, J. S., Skeate, J. G., Matsuo, K., Pham, H. Q., Lankes, H. A., Moxley, K. M., Ghamande, S. A., Lin, Y. G., Schilder, R. J., Birrer, M. J. & Kast, W. M., Nov 1 2021, In: Clinical Cancer Research. 26, 21, p. 5621-5630 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer
Rocconi, R. P., Stevens, E. E., Bottsford-Miller, J. N., Ghamande, S. A., Elder, J., DeMars, L. L., Munkarah, A., Aaron, P., Stanbery, L., Wallraven, G., Bognar, E., Manley, M., Horvath, S., Manning, L., Walter, A., Galanis, E., Herzog, T., Monk, B. J., Coleman, R. L. & Nemunaitis, J., 2021, (Accepted/In press) In: Cancer Gene Therapy.Research output: Contribution to journal › Article › peer-review
-
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers
Russo, S., Walker, J. L., Carlson, J. W., Carter, J., Ward, L. C., Covens, A., Tanner, E. J., Armer, J. M., Ridner, S., Hayes, S., Taghian, A. G., Brunelle, C., Lopez-Acevedo, M., Davidson, B. A., Schaverien, M. V., Ghamande, S. A., Bernas, M., Cheville, A. L., Yost, K. J., Schmitz, K. & 7 others, , Feb 2021, In: Gynecologic Oncology. 160, 2, p. 625-632 8 p.Research output: Contribution to journal › Review article › peer-review
-
A 73-gene proliferative transcriptomic signature predicts uterine serous carcinoma patient survival and response to primary therapy
Tran, L. K. H., Tran, P. M. H., Mysona, D. P., Purohit, S. B., Myers, E., Lee, W. S., Dun, B., Xu, D., Liu, H., Hopkins, D., Nechtman, J., Scelsi, C. L., Mittal, P. K., Kleven, D., Wallbillich, J. J., Rungruang, B., Ghamande, S. & She, J. X., May 2020, In: Gynecologic Oncology. 157, 2, p. 340-347 8 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Oza, A. M., Matulonis, U. A., Secord, A. A., Nemunaitis, J., Roman, L. D., Blagden, S. P., Banerjee, S., McGuire, W. P., Ghamande, S., Birrer, M. J., Fleming, G. F., Markham, M. J., Hirte, H. W., Provencher, D. M., Basu, B., Kristeleit, R., Armstrong, D. K., Schwartz, B., Braly, P., Hall, G. D. & 8 others, , Mar 1 2020, In: Clinical Cancer Research. 26, 5, p. 1009-1016 8 p.Research output: Contribution to journal › Article › peer-review
18 Scopus citations